Kacena MA, Plotkin LI, Fehrenbacher JC. The use of artificial intelligence in writing scientific review articles. Curr Osteoporos Rep. https://doi.org/10.1007/s11914-023-00852-0.
Margetts TJ, Karnik SJ, Wang HS, et al. Use of AI language engine ChatGPT 4.0 to write a scientific review article examining the intersection of alzheimer’s disease and bone. Curr Osteoporos Rep. 2024. https://doi.org/10.1007/s11914-023-00853-z.
Mathers CD, et al. Causes of international increases in older age life expectancy. Lancet. 2015;385(9967):540–8.
Xia X, et al. Aging and Alzheimer’s disease: comparison and associations from molecular to system level. Aging Cell. 2018;17(5): e12802.
Article PubMed PubMed Central Google Scholar
Liang W, Chikritzhs T. The effect of age on fracture risk: a population-based cohort study. J Aging Res. 2016;2016:5071438.
Article PubMed PubMed Central Google Scholar
Cheng XG, et al. Age-related bone mineral density, bone loss rate, prevalence of osteoporosis, and reference database of women at multiple centers in China. J Clin Densitom. 2007;10(3):276–84.
Friedman SM, et al. Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk. Geriatr Orthop Surg Rehabil. 2010;1(2):52–62.
Article PubMed PubMed Central Google Scholar
Tsai CH, et al. Fracture as an independent risk factor of dementia: a nationwide population-based cohort study. Medicine (Baltimore). 2014;93(26):e188.
Lui LY, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51(1):38–43.
Dev K, et al. Prevalence of falls and fractures in Alzheimer’s patients compared to general population. Cureus. 2021;13(1):e12923.
PubMed PubMed Central Google Scholar
Baker NL, et al. Hip fracture risk and subsequent mortality among Alzheimer’s disease patients in the United Kingdom, 1988–2007. Age Ageing. 2011;40(1):49–54.
Sozen T, Ozisik L, Basaran NC. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56.
• Zhang, M, Hu S and Sun X. Alzheimer’s disease and impaired bone microarchitecture, regeneration and potential genetic links. Life (Basel). 2023;13(2). This review identifies shared pathogenic mechanisms between Alzheimer’s disease (AD) and osteoporosis and suggests that treatments targeting brain disorders could also benefit osteoporotic conditions, emphasizing the importance of preventing bone loss in AD patients.
Xia WF, et al. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J Bone Miner Res. 2013;28(10):2122–35.
Article MathSciNet CAS PubMed Google Scholar
Cui S, et al. APPswe/Abeta regulation of osteoclast activation and RAGE expression in an age-dependent manner. J Bone Miner Res. 2011;26(5):1084–98.
Article CAS PubMed PubMed Central Google Scholar
Dengler-Crish CM, et al. Evidence of Wnt/beta-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer’s disease. Neurobiol Aging. 2018;67:148–58.
Article CAS PubMed Google Scholar
Dengler-Crish CM, Smith MA, Wilson GN. Early evidence of low bone density and decreased serotonergic synthesis in the Dorsal Raphe of a tauopathy model of Alzheimer’s disease. J Alzheimers Dis. 2017;55(4):1605–19.
Article CAS PubMed Google Scholar
•• JE, LL, et al. Degradation of bone quality in a transgenic mouse model of Alzheimer’s disease. J Bone Miner Res. 2022;37(12):2548-2565. This study showed that 5XFAD transgenic mice, a model for Alzheimer’s disease, exhibited altered bone quality characterized by decreased mineralization, reduced crystallinity, accumulation of advanced glycation end products (AGEs), and compromised fracture toughness, suggesting a connection between amyloid-beta accumulation in the brain and changes in bone properties.
Alzheimer’s disease facts and figures. Alzheimers Dement. 2023;19(4):1598–695.
Tabaton M, Piccini A. Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer’s disease. Int J Exp Pathol. 2005;86(3):139–45.
Article CAS PubMed PubMed Central Google Scholar
Williamson J, Goldman J, Marder KS. Genetic aspects of Alzheimer disease. Neurologist. 2009;15(2):80–6.
Article PubMed PubMed Central Google Scholar
Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol. 2009;47(4):289–99.
Riedel BC, Thompson PM, Brinton RD. Age, APOE and sex: triad of risk of Alzheimer’s disease. J Steroid Biochem Mol Biol. 2016;160:134–47.
Article CAS PubMed PubMed Central Google Scholar
Breijyeh Z and Karaman R. Comprehensive review on Alzheimer’s disease: Causes and Treatment. Molecules. 2020;25(24).
Du X, Wang X, Geng M. Alzheimer’s disease hypothesis and related therapies. Transl Neurodegener. 2018;7:2.
Article PubMed PubMed Central Google Scholar
Cras P, et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A. 1991;88(17):7552–6.
Article ADS CAS PubMed PubMed Central Google Scholar
Perl DP. Neuropathology of Alzheimer’s disease. Mt Sinai J Med. 2010;77(1):32–42.
Article PubMed PubMed Central Google Scholar
Paris D, et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett. 2004;366(1):80–5.
Article CAS PubMed Google Scholar
Chen GF, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38(9):1205–35.
Article CAS PubMed PubMed Central Google Scholar
Metcalfe MJ, Figueiredo-Pereira ME. Relationship between tau pathology and neuroinflammation in Alzheimer’s disease. Mt Sinai J Med. 2010;77(1):50–8.
Article PubMed PubMed Central Google Scholar
Heneka MT, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405.
Article CAS PubMed PubMed Central Google Scholar
Banks WA, et al. Healthy aging and the blood-brain barrier. Nat Aging. 2021;1(3):243–54.
Article PubMed PubMed Central Google Scholar
Jefferies WA, et al. Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease. Alzheimers Res Ther. 2013;5(6):64.
Article PubMed PubMed Central Google Scholar
Li W, Lo EH. Leaky memories: Impact of APOE4 on blood-brain barrier and dementia. J Cereb Blood Flow Metab. 2020;40(9):1912–4.
Article PubMed PubMed Central Google Scholar
Montagne A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71–6.
Article ADS CAS PubMed PubMed Central Google Scholar
Lee HS, et al. Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface. FEBS J. 2009;276(17):4622–35.
Article CAS PubMed Google Scholar
Paris D, et al. Inhibition of angiogenesis by Abeta peptides. Angiogenesis. 2004;7(1):75–85.
Article CAS PubMed Google Scholar
Govindpani K, et al. Vascular dysfunction in Alzheimer’s disease: a prelude to the pathological process or a consequence of it? J Clin Med. 2019;8(5).
Sarafrazi N, Wambogo EA, Shepherd JA. Osteoporosis or low bone mass in older adults: United States, 2017–2018. NCHS Data Brief. 2021;405:1–8.
Singer A, et al. Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis. Arch Osteoporos. 2023;18(1):42.
Article CAS PubMed PubMed Central Google Scholar
Brandi ML. Microarchitecture, the key to bone quality. Rheumatology (Oxford). 2009;48(4):IV3-8.
Melton LJ 3rd, et al. Fracture risk in patients with Alzheimer’s disease. J Am Geriatr Soc. 1994;42(6):614–9.
Tolppanen AM, et al. Incident hip fractures among community dwelling persons with Alzheimer’s disease in a Finnish nationwide register-based cohort. PLoS One. 2013;8(3):e59124.
Article ADS CAS PubMed PubMed Central Google Scholar
Amboni M, Barone P, Hausdorff JM. Cognitive contributions to gait and falls: evidence and implications. Mov Disord. 2013;28(11):1520–33.
留言 (0)